Evidence map›Paper›PMID 36087247›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2022

Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancer.

Chih-Yi Lin, Chung-Jen Yu, Chun-Yu Liu, Ta-Chung Chao, Chi-Cheng Huang, Ling-Ming Tseng, Jiun-I Lai

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 80% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Chih-Yi LinInstitute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Chung-Jen YuInstitute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Chun-Yu LiuSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Ta-Chung ChaoSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Chi-Cheng HuangComprehensive Breast Health Center, Taipei Veterans General Hospital, Taipei, Taiwan.
Ling-Ming TsengSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Jiun-I LaiInstitute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. jilai@nycu.edu.tw.ORCID http://orcid.org/0000-0002-8233-5466
National Yang Ming Chiao Tung University · TWTaipei Veterans General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36087247
OpenAlexW4296295688

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.